Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Despite tremendous efforts in the search for safe, efficacious and non-addictive opioids for pain treatment, morphine remains the most valuable painkiller in contemporary medicine. Opioids exert their pharmacological actions through three opioid-receptor classes, mu, delta and kappa, whose genes have been cloned. Genetic approaches are now available to delineate the contribution of each receptor in opioid function in vivo. Here we disrupt the mu-opioid-receptor gene in mice by homologous recombination and find that there are no overt behavioural abnormalities or major compensatory changes within the opioid system in these animals. Investigation of the behavioural effects of morphine reveals that a lack of mu receptors abolishes the analgesic effect of morphine, as well as place-preference activity and physical dependence. We observed no behavioural responses related to delta- or kappa-receptor activation with morphine, although these receptors are present and bind opioid ligands. We conclude that the mu-opioid-receptor gene product is the molecular target of morphine in vivo and that it is a mandatory component of the opioid system for morphine action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, in animal models, dopamine D1 receptor knockout rats will not self-administer cocaine37 and μ opioid receptor knockout mice will not show the rewarding effects of opioids.153”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [153]
In the citing paper
“Mice that lack the MOR gene do not develop place preferences or withdrawal symptoms in response to morphine (Matthes et al 1996).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Matthes et al 1996
Citations
Cites
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Self-citationNeutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
Self-citationLufkin, T., Dierich, A., LeMeur, M., Mark, M., & Chambon, P. (1991) · Cell · doi:10.1016/0092-8674(91)90034-v · Cited by 697
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M., & Nestler, E. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)91111-d · Cited by 535
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Multiple opioid receptors: ligand selectivity profiles and binding site signatures.
Goldstein, A., & Naidu, A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09190-4 · Cited by 445
Kieffer, B. L. (1995) · Cellular and Molecular Neurobiology · doi:10.1007/bf02071128 · Cited by 389
Self-citationReduction of Morphine Abstinence in Mice with a Mutation in the Gene Encoding CREB
Maldonado, R., Blendy, J. A., Tzavara, E., Gass, P., Roques, B. P., Hanoune, J., & Schütz, G. (1996) · Science · doi:10.1126/science.273.5275.657 · Cited by 292
Self-citationThe mouse Pgk-1 gene promoter contains an upstream activator sequence
McBurney, M. W., Sutherland, L. C., Adra, C. N., Leclair, B., Rudnicki, M. A., & Jardine, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5755 · Cited by 193
Research works printed but not linked: 9
- Goldstein, A. & Naidu, A. Mol. Pharmacol. 36, 265–272 (1989).
- Pasternak, G. W. Clin. Pharmacol. 16, 1–18 (1993).
- Cowan, A. in Handbook of Experimental Pharmacology Opioids II (ed. Herz, A.) Vol. 104, 393–414 (Springer, Berlin, 1993).
- Roques, B. P., Noble, F., Daugé, V., Fournié-Zaluski, M.-C. & Beaumont, A. Pharmacol. Rev. 45, 87–146 (1993).
- Baamonde, A., Daugé, V., Gacel, C. & Roques, B. P. J. Pharmacol. Exp. Ther. 257, 767–773 (1991).
- Koob, G. F. Trends Biochem. Sci. 13, 177–184 (1992).
- Wei, E. T. J. Pharmacol. Exp. Ther. 216, 12–18 (1981).
- Cowan, A., Zhu, X. Z., Mosberg, H. I., Omnaas, J. R. & Porreca, F. J. Pharmacol. Exp. Ther. 246, 950–955 (1988).
- Kitchen, I. et al. J. Pharmacol. Exp. Ther. 275, 1595–1607 (1995).
Cited by
Neurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Self-citationThe biopsychosocial approach to chronic pain: Scientific advances and future directions.
Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N., & Turk, D. C. (2007) · Psychological Bulletin · doi:10.1037/0033-2909.133.4.581 · Cited by 3,392
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
“…that the mu opioid receptor subtype appears to be particularly important for the reinforcing actions of heroin and morphine (Negus et al. 1993), and knockout mice without the mu receptor fail to show morphine-induced analgesia or morphineinduced conditioned place preference (Matthes et al. 1996).”
BackgroundDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Tzschentke, T. M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00060-4 · Cited by 1,266
“The induction of CPP has also been demonstrated for the psychostimulants and DA reuptake blockers (À)-amphetamine (Timar et al., 1996), cocaethylene (Schechter, 1995; Kushner, 1997), cathinone (Calcagnetti and Schechter, 1992a; Schechter and Meehan, 1993; Schechter and McBurney, 1991), fencamfamine…”
BackgroundInfluentialThe genetics of addictions: uncovering the genes
Goldman, D., Oroszi, G., & Ducci, F. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1635 · Cited by 1,099
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Pain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,064
“Greater success is achieved by pharmacologic manipulation of inhibitory circuits, in particular ligands for the opioid receptor, which mediate all of the actions of morphine (20).”
BackgroundKoob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Reward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
“Morphine (240, 253, 350) and heroin (71, 234) CPP as well as morphine self-administration (30) were abolished in the mu mutant.”
Self-citationdepue, R. A., & morrone-strupinsky, J. V. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000063 · Cited by 958
“Indeed, transgenic mice lacking the uOR gene show no morphine-induced place preferences or physical dependence from morphine consumption, whereas morphine induces both of these behaviors in wild-type mice (Matthes et al. 1996; Simonin et al. 1998).”
Backgroundμ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
“These include: (1) The unliganded, inactive μOR, prepared by deleting the covalently bound, co-crystallized ligand, β-FNA, and adding a proton in its place to K2335.”
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
“…as well as disrupted morphine-induced locomotor activity, hypothermia, respiratory suppression, gastrointestinal disturbances, tolerance to chronic treatment, dependence, and withdrawal, was observed in mice lacking the µOR (Kieffer 1999, Loh et al. 1998, Matthes et al. 1996, Uhl et al. 1999).”
BackgroundRegional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2001) · Science · doi:10.1126/science.1060952 · Cited by 841
Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
“This hypothesis is not supported by data from m-opioid receptor (MOR) knockout mice, (Matthes et al., 1996) demonstrating that most morphine-induced actions require the MOR and a truly nonaddictive opioid agonist has not been identified.”
BackgroundResultOpioids and the control of respiration
Pattinson, K. T. S. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen094 · Cited by 793
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779
“In this regard, -opioid receptor-mediated neurotransmission is one of the principal systems involved in the modulation of pain (Matthes et al., 1996), stress responses (Akil et al.”
BackgroundCrawley, J. N. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01258-x · Cited by 761
Waldhoer, M., Bartlett, S. E., & Whistler, J. L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073940 · Cited by 740
Polydrug abuse: a review of opioid and benzodiazepine combination use
Jones, J. D., Mogali, S., & Comer, S. D. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.004 · Cited by 703
Regulation and Role of Adenylyl Cyclase Isoforms
Hanoune, J., & Defer, N. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.145 · Cited by 691
Self-citationMice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Self-citationStructure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 658
Molecular Mechanisms and Regulation of Opioid Receptor Signaling
Law, P.-Y., Wong, Y. H., & Loh, H. H. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.389 · Cited by 661
Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00197-3 · Cited by 656
“The conclusions of other studies are reinforced by these data since the KO mice display 'C57BL/6-like' phenotypes less likely to be associated with hitchhiking 129-derived alleles (Matthes et al., 1996; Rupniak et al., 1997; Sora et al., 1997; Xu et al., 1997).”
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
“In rodents, these effects are reversible by MOR antagonists and absent in MOR knockout animals (Matthes et al., 1996; Sora et al., 1997; Kieffer, 1999), indicating they are “on-target” and cannot be improved by increasing receptor selectivity.”
BackgroundExploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620
Self-citationThe molecular dynamics of pain control
Hunt, S. P., & Mantyh, P. W. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053509 · Cited by 610
Management of Opioid Analgesic Overdose
Boyer, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1202561 · Cited by 605
Mu Opioids and Their Receptors: Evolution of a Concept
Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
“Both the analgesic and respiratory suppressive effects of opioids are due the activation of the mu opioid receptor (MOR) (Dahan et al., 2001; Matthes et al., 1996).”
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Music and social bonding: “self-other†merging and neurohormonal mechanisms
Tarr, B., Launay, J., & Dunbar, R. I. M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.01096 · Cited by 548
“Given the role of endorphins in bonding in other species, it is plausible that the EOS may also underpin human social bonds (Matthes et al., 1996; Moles et al., 2004; Depue and Morrone-Strupinsky, 2005; Dunbar, 2010).”
BackgroundG protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
A unified framework for addiction: Vulnerabilities in the decision process
Redish, A. D., Jensen, S., & Johnson, A. (2008) · Behavioral and Brain Sciences · doi:10.1017/s0140525x0800472x · Cited by 501
Opioids: first lessons from knockout mice
Kieffer, B. L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01279-6 · Cited by 489
Self-citationHeterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., & Devi, L. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-j0007.2000 · Cited by 403
“Studies with transgenic animals lacking m receptors show that morphine functions primarily via m receptors (Matthes et al., 1996).”
BackgroundDissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain
Scherrer, G., Imamachi, N., Cao, Y.-Q., Contet, C., Mennicken, F., O'Donnell, D., Kieffer, B. L., & Basbaum, A. I. (2009) · Cell · doi:10.1016/j.cell.2009.04.019 · Cited by 462
“For example, several groups reported either a decrease or a total loss of the activity of DOR agonists in tests of heat pain in mor null mice (Gendron et al., 2007; Matthes et al., 1996; Scherrer et al., 2004; Sora et al., 1997a).”
BackgroundInfluentialSelf-citationDeficit in Attachment Behavior in Mice Lacking the µ-Opioid Receptor Gene
Moles, A., Kieffer, B. L., & D'Amato, F. R. (2004) · Science · doi:10.1126/science.1095943 · Cited by 449
Self-citationMorphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
Ferrini, F., Trang, T., Mattioli, T.-A. M., Laffray, S., Del'Guidice, T., Lorenzo, L.-E., Castonguay, A., Doyon, N., Zhang, W., Godin, A. G., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3295 · Cited by 437
Spruijt, B. M., van den Bos, R., & Pijlman, F. T. A. (2001) · Applied Animal Behaviour Science · doi:10.1016/s0168-1591(00)00204-5 · Cited by 436
Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
Maldonado, R., Saiardi, A., Valverde, O., Samad, T. A., Roques, B. P., & Borrelli, E. (1997) · Nature · doi:10.1038/41567 · Cited by 434
Self-citationThe genetic mediation of individual differences in sensitivity to pain and its inhibition
Mogil, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7744 · Cited by 434
Accelerated Evolution of Nervous System Genes in the Origin of Homo sapiens
Dorus, S., Vallender, E. J., Evans, P. D., Anderson, J. R., Gilbert, S. L., Mahowald, M., Wyckoff, G. J., Malcom, C. M., & Lahn, B. T. (2004) · Cell · doi:10.1016/j.cell.2004.11.040 · Cited by 432
Zhu, Y., King, M. A., Schuller, A. G. P., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E., Pasternak, G. W., & Pintar, J. E. (1999) · Neuron · doi:10.1016/s0896-6273(00)80836-3 · Cited by 430
Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418
“We have demonstrated previously that the main biological actions of morphine are abolished in mutant mice lacking the MOR, including analgesia, reward and physical dependence (Matthes et al., 1996).”
BackgroundInfluentialSelf-citationFunctional Dissociation of μ Opioid Receptor Signaling and Endocytosis
Whistler, J. L., Chuang, H.-H., Chu, P., Jan, L. Y., & von Zastrow, M. (1999) · Neuron · doi:10.1016/s0896-6273(01)80032-5 · Cited by 413
Tzschentke, T. M., Christoph, T., Kögel, B., Schiene, K., Hennies, H.-H., Englberger, W., Haurand, M., Jahnel, U., Cremers, T. I. F. H., Friderichs, E., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.126052 · Cited by 395
“However, cloning of the opioid receptors and the investigation of MOR knockout mice (Matthes et al., 1996) strongly suggest that both the analgesic activity and side effects of morphine-like analgesics are mediated by the same receptor (sub)type.”
BackgroundPharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391
“…this receptor as essential for morphine analgesia, physical dependence, and reward as measured by antinociception, withdrawal, conditioned place preference, and self-administration studies (Matthes et al., 1996; Sora et al., 1997; Kitanaka et al., 1998; Loh et al., 1998; Becker et al., 2000).”
BackgroundTissue specificity and physiological relevance of various isoforms of adenylyl cyclase
Defer, N., Best-Belpomme, M., & Hanoune, J. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f400 · Cited by 389
Self-citationOpioid-induced hyperalgesia: Cellular and molecular mechanisms
Roeckel, L.-A., Le Coz, G.-M., Gavériaux-Ruff, C., & Simonin, F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.029 · Cited by 388
Self-citationFunctional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J. A., Gómez, R., del Arco, I., Villanúa, M. A., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05344.2001 · Cited by 378
“Among them, the m receptor has been identified as the major contributor to opiate dependence (Matthes et al., 1996; Kieffer, 1999).”
BackgroundSelf-citationSmith, Y. R., Stohler, C. S., Nichols, T. E., Bueller, J. A., Koeppe, R. A., & Zubieta, J.-K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5223-05.2006 · Cited by 378
Kreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Morphine-activated opioid receptors elude desensitization by β-arrestin
Whistler, J. L., & von Zastrow, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9914 · Cited by 370
Dynorphin Acts as a Neuromodulator to Inhibit Itch in the Dorsal Horn of the Spinal Cord
Kardon, A. P., Polgár, E., Hachisuka, J., Snyder, L. M., Cameron, D., Savage, S., Cai, X., Karnup, S., Fan, C. R., Hemenway, G. M., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.046 · Cited by 369
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Gillis, A., Gondin, A. B., Kliewer, A., Sanchez, J., Lim, H. D., Alamein, C., Manandhar, P., Santiago, M., Fritzwanker, S., Schmiedel, F., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz3140 · Cited by 336
“The antinociceptive action of these compounds has been shown to be abolished in MOR knockout animals (16, 19, 36, 37) or to be sensitive to the MOR antagonist naloxone (11).”
Backgroundμ-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05100.2002 · Cited by 363
“-Opioid receptors mediate the action of exogenously administered opiate drugs and antinociceptive responses to sustained or repetitive stressful and painful stimuli (Watkins and Mayer, 1982; Akil et al., 1984; Terman et al., 1984; Matthes et al., 1996).”
BackgroundOpioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 352
Self-citationCorder, G., Tawfik, V. L., Wang, D., Sypek, E. I., Low, S. A., Dickinson, J. R., Sotoudeh, C., Clark, J. D., Barres, B. A., Bohlen, C. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4262 · Cited by 348
Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization
He, L., Fong, J., von Zastrow, M., & Whistler, J. L. (2002) · Cell · doi:10.1016/s0092-8674(02)00613-x · Cited by 339
The presence of Cholinomimetic and calcium channel antagonist constituents in Piper betle Linn.
Gilani, A. H., Aziz, N., Khurram, I. M., Rao, Z. A., & Ali, N. K. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6<436::aid-ptr620>3.0.co;2-c · Cited by 35
Naturally occurring antinociceptive substances from plants
Calixto, J. B., Beirith, A., Ferreira, J., Santos, A. R. S., Filho, V. C., & Yunes, R. A. (2000) · Phytotherapy Research · doi:10.1002/1099-1573(200009)14:6<401::aid-ptr762>3.0.co;2-h · Cited by 339
Dysregulation of Endogenous Opioid Emotion Regulation Circuitry in Major Depression in Women
Kennedy, S. E., Koeppe, R. A., Young, E. A., & Zubieta, J.-K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1199 · Cited by 338
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
μ Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality
Loh, H. H., Liu, H.-C., Cavalli, A., Yang, W., Chen, Y.-F., & Wei, L.-N. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00353-7 · Cited by 337
Mu opioid receptor: a gateway to drug addiction
Contet, C., Kieffer, B. L., & Befort, K. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.005 · Cited by 332
Self-citationCurrent Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Neurobiology of Addiction: Toward the Development of New Therapies
KOOB, G. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06682.x · Cited by 317
Keith, D. E., Antón, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & von Zastrow, M. (1998) · PubMed · Cited by 317
Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis—Part 2
Martin, V. T., & Behbehani, M. (2006) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00370.x · Cited by 309
Roy, S., Ninkovic, J., Banerjee, S., Charboneau, R. G., Das, S., Dutta, R., Kirchner, V. A., Koodie, L., Ma, J., Meng, J., et al. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9292-5 · Cited by 309
“MOR is considered to be the major molecular target of morphine (Matthes et al. 1996).”
BackgroundSchuller, A. G. P., King, M. A., Zhang, J., Bolan, E., Pan, Y., Morgan, D. J., Chang, A., Czick, M. E., Unterwald, E. M., Pasternak, G. W., et al. (1999) · Nature Neuroscience · doi:10.1038/5706 · Cited by 307
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Paul, A. K., Smith, C. M., Rahmatullah, M., Nissapatorn, V., Wilairatana, P., Spetea, M., Gueven, N., & Dietis, N. (2021) · Pharmaceuticals · doi:10.3390/ph14111091 · Cited by 300
The Opioid Epidemic: Crisis and Solutions
Skolnick, P. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052534 · Cited by 307
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307
“Mice that lack the MOR gene do not develop place preferences or withdrawal symptoms in response to morphine (Matthes et al. 1996; for a complete review of this topic, see Le Merrer et al. 2009).”
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01405-4 · Cited by 303
“Recently, it has been shown that in knockout mice lacking the m-opioid receptor gene, morphine did not induce conditioned place preference (Matthes et al., 1996).”
Backgroundmu-Opioid receptor knockout mice do not self-administer alcohol.
Roberts, A. J., McDonald, J. S., Heyser, C. J., Kieffer, B. L., Matthes, H. W. D., Koob, G. F., & Gold, L. H. (2000) · PubMed · Cited by 303
Self-citationHoehe, M. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.19.2895 · Cited by 290
“Its gene product is the principal molecular target of morphine, mediating reward, tolerance and dependence (17,18).”
BackgroundCastro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 290
Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids
Liu, X.-Y., Liu, Z.-C., Sun, Y.-G., Ross, M., Kim, S., Tsai, F.-F., Li, Q.-F., Jeffry, J., Kim, J.-Y., Loh, H. H., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.043 · Cited by 291
“Mice lacking the Oprm gene displayed loss of MIA (Loh et al., 1998; Matthes et al., 1996; Sora et al., 1997).”
BackgroundOpioids: cellular mechanisms of tolerance and physical dependence
Bailey, C. P., & Connor, M. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.08.012 · Cited by 285
Endocytosis of the Mu Opioid Receptor Reduces Tolerance and a Cellular Hallmark of Opiate Withdrawal
Finn, A. K., & Whistler, J. L. (2001) · Neuron · doi:10.1016/s0896-6273(01)00517-7 · Cited by 285
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Zhuang, Y., Wang, Y., He, B., He, X., Zhou, X. E., Guo, S., Rao, Q., Yang, J., Liu, J., Zhou, Q., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.041 · Cited by 273
Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse
Liu, Y., Li, D., Liu, Z., Zhou, Y., Chu, D., Li, X., Jiang, X., Hou, D., Chen, X., Chen, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep17543 · Cited by 280
Peckys, D., & Landwehrmeyer, G. B. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00251-6 · Cited by 278
Keith, D. E., Anton, B., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Monteillet-Agius, G., Stewart, P. L., Evans, C. J., & Zastrow, M. V. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.377 · Cited by 276
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Lacagnina, M. J., Rivera, P. D., & Bilbo, S. D. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.121 · Cited by 271
“…Gi/o-coupled opioid receptors—μ, δ, and κ receptors— but the reinforcing effects are largely attributed to their signaling at μ-opioid receptors (Matthes et al, 1996), which is due in part to suppression of local GABAergic inhibition of VTA dopamine neurons (Di Chiara and Imperato, 1988;…”
BackgroundNeural Systems Underlying Opiate Addiction
De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270
“Blockade of MORs but not other opioid receptors attenuates opiate selfadministration, and constitutive deletion of MORs attenuates the conditioned preferences that animals exhibit for contextual cues previously associated with opiate administration (Negus et al., 1993; Matthes et al., 1996).”
BackgroundOpioid Tolerance Development: A Pharmacokinetic/Pharmacodynamic Perspective
Dumas, E. O., & Pollack, G. M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9056-1 · Cited by 269
An essential role for ΔFosB in the nucleus accumbens in morphine action
Zachariou, V., Bolanos, C. A., Selley, D. E., Theobald, D., Cassidy, M. P., Kelz, M. B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L. J., Dileone, R. J., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1636 · Cited by 266
Gulyás, A. I., Szabó, G. G., Ulbert, I., Holderith, N., Monyer, H., Erdélyi, F., Szabó, G., Freund, T. F., & Hájos, N. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4104-10.2010 · Cited by 262
“In addition, -opiate receptor (MOR) knock-out (KO) mice (Matthes et al., 1996) were used to test the specificity of DAMGO ([D-Ala 2,N-MePhe 4,Gly 5-ol]enkephalin acetate) effects, which were compared with the effects obtained in their wild-type (WT) littermates.”
Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors
Ghozland, S., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263
“The generation of mice lacking either -opioid (MOR / ), -opioid (DOR / ), or -opioid (KOR / ) receptors has been described previously (Matthes et al., 1996; Simonin et al., 1998; Filliol et al., 2000).”
BackgroundSelf-citationNishi, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1858 · Cited by 261
Propagation of conformational changes during μ-opioid receptor activation
Sounier, R., Mas, C., Steyaert, J., Laeremans, T., Manglik, A., Huang, W., Kobilka, B. K., Déméné, H., & Granier, S. (2015) · Nature · doi:10.1038/nature14680 · Cited by 255
Identification and Characterization of Three New Alternatively Spliced μ-Opioid Receptor Isoforms
Pan, Y.-X., Xu, J., Bolan, E., Abbadie, C., Chang, A., Zuckerman, A., Rossi, G., & Pasternak, G. W. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12651-x · Cited by 254
Metadata
- Authors
- Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B. P., & Kieffer, B. L.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Surrey (GB)
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- Inserm (FR)
- Venue
- Nature
- Published
- 1996-10
- Volume
- 383
- Issue
- 6603
- Pages
- 819-823
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051746492
- Cited by
- 1,722
- References
- 25
- Citations by year
- 2026: 36 · 2025: 40 · 2024: 45 · 2023: 52 · 2022: 53 · 2021: 56 · 2020: 59 · 2019: 56 · 2018: 53 · 2017: 43 · 2016: 59 · 2015: 53 · 2014: 60 · 2013: 65 · 2012: 58
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- mu-opioid receptor, morphine, analgesia, opioid reward, place preference, opioid withdrawal, physical dependence, knockout mice, delta opioid receptor, kappa opioid receptor, opioid system, pain management
- MeSH terms
- Analgesics, Animals, Behavior, Animal, Cell Line, Enkephalins, Mice, Inbred C57BL, Morphine, Morphine Dependence, Narcotics, Reward, Substance Withdrawal Syndrome, Gene Deletion, Receptors, Opioid, mu, Receptors, Opioid, delta, Receptors, Opioid, kappa, Mice, Knockout, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.